Fact CheckerSign in

NCT06540391Active, not recruitingPhase 1

A Phase 1b, Randomized, Open-Label Trial to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB097 in Combination with Pembrolizumab in Melanoma Patients with Primary Resistance to an Anti-PD-1-Containing Immunotherapy (MELODY-1)

Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Apr 2026

Status (registry)
Active, not recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
27 (estimated)
First submitted
28 Mar 2024
Start date
28 Aug 2024
Lead sponsor
Microbiotica Limited
Diseases
Melanoma
NCT number
NCT06540391
EU CT number
2023-507377-17-00

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 27
  • 12 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (12)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Universitario HM Sanchinarro
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario Ramón y Cajal
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario 12 de Octubre
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital General Universitario de Valencia
Coordinator of this site? Confirm its status
ValenciaSpainCompleted
Centr Georges Francois Leclerc
Coordinator of this site? Confirm its status
DijonFranceActive, not recruiting
Centre Hospitalier Universitaire De Lille
Coordinator of this site? Confirm its status
Lille CedexFranceActive, not recruiting
Centre Leon Berard
Coordinator of this site? Confirm its status
LyonFranceActive, not recruiting
Centre Hospitalier Regional De Marseille
Coordinator of this site? Confirm its status
MarseilleFranceActive, not recruiting
Hospices Civils de Lyon
Coordinator of this site? Confirm its status
Pierre-BéniteFranceActive, not recruiting
Istituto Europeo di Oncologia s.r.l
Coordinator of this site? Confirm its status
MilanItalyActive, not recruiting
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Coordinator of this site? Confirm its status
NaplesItalyActive, not recruiting
Humanitas Mirasole S.p.A.
Coordinator of this site? Confirm its status
RozzanoItalyActive, not recruiting

This page is information, not medical advice. Discuss any trial with your doctor.